Introduction The clinical differentiation of Parkinson's disease (PD) from multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) may be challenging, especially in their early stages. The aim of this study was to evaluate the utility of apparent diffusion coefficient (ADC) measurement to distinguish among these degenerative disorders. Methods Twenty-five MSA, 20 PSP, and 17 PD patients and 18 healthy controls were retrospectively studied. Axial diffusion-weighted and T2-weighted images were obtained using a 3-T MR system. Regions of interest (ROIs) were precisely placed in the midbrain, pons, putamen, globus pallidus, caudate nucleus, thalamus, superior cerebellar peduncle, middle cerebellar peduncle, cerebellar white matter, and cerebellar dentate nucleus, and the regional ADC (rADC) value was calculated in each ROI. Results In MSA, rADC values in the pons, middle cerebellar peduncle, cerebellar white matter, and cerebellar dentate nucleus were significantly higher than in PSP, PD, and controls. Furthermore, rADC values in the posterior putamen were significantly higher in MSA than in PSP and controls.
Introduction
Based on clinical findings alone, Parkinson's disease (PD) is often difficult to discriminate from other degenerative disorders with parkinsonism, such as multiple system atrophy (MSA) or progressive supranuclear palsy (PSP), because of similarities in their clinical presentations. Therefore, the clinical differentiation of PD from MSA and PSP may be challenging [1] , especially in their early stages. However, it is extremely important to differentiate these diseases because of their differences in prognosis, treatment response, and molecular pathogenesis.
MSA is characterized pathologically by degeneration of the inferior olivary nucleus, pons, cerebellum, middle cerebellar peduncle, and striatum, as well as the substantia nigra [2, 3] , and PSP is characterized by degeneration of the globus pallidus, striatum, hypothalamic nucleus, midbrain (especially in the tectal and tegmental regions, substantia nigra, and red nucleus), pons, superior cerebellar peduncle, and cerebellar dentate nucleus [4] , while PD is characterized by degeneration of the substantia nigra and locus ceruleus. Degeneration of the striatum in MSA cases, especially in cases with parkinsonism, is characteristically seen with anterior to posterior gradients of histological severity [5] . Furthermore, degeneration of the globus pallidus in PSP cases is characteristically seen with lateral to medial gradients of histological severity.
Brain imaging techniques are important tools to investigate the pathogenesis of PD and other degenerative disorders with parkinsonism in vivo. Magnetic resonance (MR) imaging has been widely used to differentiate atypical parkinsonian syndromes from PD. Previous studies have demonstrated that conventional MR imaging sequences are useful for differentiating MSA, PSP, and PD [6] [7] [8] [9] . On conventional MR imaging, signal changes associated with iron deposition (increased tissue iron content shortens the T2 value) and/or content of water due to tissue rarefaction (increased water content lengthens the T2 value) and the degree of atrophy have been assessed in degenerative disorders [10] [11] [12] [13] . However, it has often been difficult to differentiate these diseases in their early stages by conventional MR imaging alone.
In recent years, many reports have shown that diffusionweighted imaging (DWI) is sensitive to microstructural brain damage. DWI has been applied to several kinds of central nervous system diseases, such as cerebral ischemia, multiple sclerosis, and brain tumors. Apparent diffusion coefficient (ADC) is a quantitative index of water diffusivity derived from DWI. In the central nervous system, the water diffusivity is highly restricted by tissue architecture of fiber tracts. But when neuropathological changes, such as neuronal loss and gliosis, occur, this tissue architecture is destroyed, and the water diffusivity increases. As a result, elevation of ADC value is observed [14, 15] . Therefore, ADC values reflect the degree of destruction of tissue architecture due to neuronal loss and gliosis in neurodegenerative diseases, and several studies have reported that measurements of regional ADCs (rADCs) were useful for differentiation of these diseases [16] [17] [18] [19] [20] . Also, in degenerative disorders, increased rADC values reflecting histopathological change can be detected on DWI before T2 signal changes and/or atrophy is detected on conventional MR imaging [1, 20, 21] . Furthermore, DWI can be performed in a short time and evaluation of rADC value is a clinically practical method. Application of 3-Tesla (3-T) systems makes it possible to obtain higher resolution images, which allow visualization of brain anatomies in fine detail, in comparison with 1.5-T systems [22, 23] . However, to the best of our knowledge, there has been no study concerning degenerative cause of parkinsonism by ADC measurement using 3-T systems. The aim of this study was to evaluate the utility of ADC measurement to distinguish among MSA, PSA, and PD, by accurately placing regions of interest (ROIs) in the characteristic anatomical regions affected by these diseases with parkinsonism, using 3-T MR imaging.
Materials and methods

Patients
A total of 25 patients with a clinical diagnosis of MSA (5 patients with predominant parkinsonian symptoms (MSA-P), 20 patients with predominant cerebellar symptoms (MSA-C), 13 men, 12 women), 20 patients with a clinical diagnosis of PSP (14 men, 6 women), 17 patients with a clinical diagnosis of PD (8 men, 9 women), and 18 age-matched healthy controls (8 men, 10 women) were studied retrospectively. The clinical diagnoses of MSA, PSP, and PD were determined according to established consensus criteria by experienced neurologists in our hospital [24] [25] [26] . Patients with a definite diagnosis of each disease were enrolled in this study during the past 7 years. None of the healthy control participants had a history of central nervous system diseases, and all of them had normal results on neurological examination. The retrospective review of patient records for this study was approved by the IRB at our institution.
MRI protocol
All MR images were acquired on a 3-T MR imaging system (Signa Horizon, GE Healthcare, Milwaukee, WI, USA). Axial DWI was obtained using a spin echo echo planar imaging sequence (TR/TE, 6,000/65; 128 × 160 matrix; 210-mm FOV; section thickness/intersection gap, 5/1.5 mm). Diffusion-sensitizing gradients were applied in three orthogonal directions with two different b values (0 and 1,000 s/mm 2) . Furthermore, axial T2-weighted fast spin echo (FSE) images (TR/TE, 6,000/65; 512×320 matrix; 210-mm FOV; section thickness/intersection gap, 5/1.5 mm) were also obtained.
Data analysis
ADC maps were created by signals obtained from images with two different b values (0, 1,000 s/mm 2 ). Anatomical ROIs were definitely identified on the T2-weighted b00 s/mm 2 images, compared to the T2-weighted FSE images. ROIs were defined manually in the head of the caudate nucleus, thalamus, putamen, globus pallidus, midbrain (entire portion except aqueduct), pons (entire portion) and superior cerebellar peduncle, middle cerebellar peduncle, cerebellar dentate nucleus, and cerebellar white matter. Furthermore, ROIs were placed in the anterior, intermediate, and posterior parts of the putamen and in the medial and lateral parts of the globus pallidus. The ROIs were strictly traced on margins of anatomical regions and placed to avoid a few hyperintense spots and dilated perivascular spaces. The rADC value was obtained by calculating a mean number of values of all pixels within a ROI. The rADC values, namely mean rADC values, were obtained on both sides of the anatomical regions except the midbrain and pons. As to the midbrain and pons, each mean rADC value was calculated by placing the ROI within the entire midbrain and pons, respectively. All images were analyzed by a single experienced neuroradiologist (K.T). Representative images of the ROIs are shown in Fig. 1 .
Statistical analysis
The Kruskal-Wallis test was used to compare mean rADC values among the MSA group, PSP group, PD group, and healthy control group. Also, the same test was used to compare mean rADC values between the MSA-P group and the MSA-C group. Data are expressed as means ± SD in Tables 1 and 2 . Furthermore, multiple group comparisons (MSA group, PSP group, PD group, and healthy control group) were performed using the Mann-Whitney U test. All statistical analyses were performed on a personal computer. P values of less than 0.05 were considered significant.
Results
Patient age was not significantly different among the groups at the time of MR examination. The mean age at examination was 64.7 (SD 8.2) years in the MSA group, 74.6 (SD 5.7) years in the PSP group, 71.1 (SD 6.3) years in the PD group, and 66.3 (SD 9.9) years in the control group.
Disease duration was significantly different between the MSA and the PD groups (P00.015). The mean years of disease duration were 3.4 (SD 2.6) years in the MSA group, 4.0 (SD 3.0) years in the PSP group, and 6.0 (SD 3.0) years in the PD group. The rADC values (mean ± SD) and scatterplot graphs of the rADC values in each anatomical region are shown in Tables 1 and 2 and Fig. 2 .
Anatomical regions
In the midbrain, rADC values were significantly higher in the PSP group than in the MSA, PD, and control groups. In the pons, middle cerebellar peduncle, cerebellar white matter, and dentate nucleus, the rADC values were significantly higher in the MSA group than in the PSP, PD, and control groups. In the superior cerebellar peduncle, the rADC values were significantly higher in the PSP group than in the MSA and control groups. In the head of the caudate nucleus, the rADC values were significantly higher in the PSP group than in the MSA and control groups.
As to the putamen, there were no significant differences in the rADC values among the entire, anterior, and intermediate putamen, although the rADC values in the posterior putamen were significantly higher in the MSA group than in the PSP and control groups. In the globus pallidus (both entire and each part of the globus pallidus), the rADC values were significantly higher in the PSP group than in the MSA, PD, and control groups. In the thalamus, there was no significant difference in the rADC values among the groups.
MSA, PSP, and PD
In the MSA group, the rADC values in the pons, middle cerebellar peduncle, cerebellar white matter, and cerebellar dentate nucleus were significantly higher than in PSP, PD, and control groups. Furthermore, the rADC values in the posterior putamen were significantly higher in the MSA group than in the PSP and control groups. In comparison between the MSA-P and MSA-C groups, the rADC values in the entire putamen, posterior part of putamen, entire globus pallidus, lateral part of globus pallidus, and head of caudate nucleus were significantly higher in the MSA-P group than in the MSA-C group. The rADC values in the pons, middle cerebellar peduncle, and cerebellar white matter were significantly higher in the MSA-C group than in the MSA-P group.
In the PSP group, the rADC values were significantly higher in the globus pallidus and midbrain than in the MSA, PD, and control groups. Furthermore, the rADC values in the head of the caudate nucleus and superior cerebellar peduncle were significantly higher in the PSP group than in the MSA and control groups. In the PD group, there was no significant increase in the rADC values compared to the MSA, PSP, and control groups in all regions.
Discussion
In the present study, the ADC values of characteristic lesions in the MSA and PSP groups were significantly increased. These findings seemed to reflect the histological degenerative changes, such as neuronal loss, gliosis, and tissue rarefaction, seen in each degenerative disorder [2, 3] . In the MSA group, rADC values in the posterior putamen, midbrain, pons, middle cerebellar peduncle, and cerebellar white matter were significantly higher, pathologically consistent with the characteristic lesions in MSA [2, 3] . MSA is categorized by its clinical features into two subtypes, MCA-C and MSA-P. Clinically, in some cases, there is some overlap in symptoms between the two subtypes [21] . Pathologically, degenerative changes are seen in the pons, middle cerebellar peduncle, and cerebellar hemisphere in MSA-C cases [8] . On the other hand, lesions are seen in the substantia nigra and the striatum (especially in the posterior region) in MSA-P cases. In our comparison between the MSA-P and MSA-C groups, the rADC values in the putamen, globus pallidus, and head of caudate nucleus were significantly higher in the MSA-P group than in the MSA-C group. The rADC values in the pons, middle cerebellar peduncle, and cerebellar white matter were significantly higher in the MSA-C group than in the MSA-P group. These findings reflected characteristic lesions in MSA-P and MSA-C. However, it is known that these degenerative changes extend to whole regions in both MSA-C and MSA-P with disease progression [2, 3, 11, 27] .
Previous similar studies have shown that rADC values were increased in the middle cerebellar peduncles and pons even in cases with MSA-P [8, 14, 15, 20] . Therefore, it is important to evaluate all of these regions in both MSA-P and MSA-C to differentiate MSA, PSP, and PD. , globus pallidus (entire, medial, lateral), caudate nucleus (head), thalamus, midbrain, pons, superior cerebellar peduncle, middle cerebellar peduncle, cerebellar white matter, and cerebellar dentate nucleus in patients with MSA, MSA-P, MSA-C, PSP, and PD, and healthy controls. *P values<0.05, significant difference by using the Mann-Whitney U test Fig. 2 (continued) Furthermore, rADC values were significantly increased in the posterior part of the putamen, but no significant differences were detected in the head of the caudate nucleus and the whole, anterior, and intermediate parts of the putamen in the MSA group. Several studies reported that elevation of rADC values in the putamen was not useful to differentiate MSA from PSP and PD [16, 17] . However, in these studies, the ROIs were placed in the entire putamen without considering the gradient severity of striatal degeneration in MSA. In the present study, the ROIs were placed distinctly in the head of the caudate nucleus, and the anterior, intermediate, and posterior parts of the putamen. The increases in the rADC values in the posterior part of the putamen, namely the posterior part of the striatum, were consistent with the histological severity of the posterior striatal lesion in MSA. Therefore, measurement of rADC values in the posterior part of the putamen, that is the posterior part of the striatum, is important in discriminating MSA from PSP and PD.
Degeneration is not pathologically seen in the cerebellar dentate nucleus in MSA, although elevated rADC values were detected in the cerebellar dentate nucleus in the MSA group in the present study. The elevated rADC values might reflect degeneration in the cerebellar white matter around the cerebellar dentate nucleus [1, 20] .
In the PSP group, the rADC values in the globus pallidus, head of the caudate nucleus, midbrain, and superior cerebellar peduncles were significantly increased compared to the MSA, PD, and control groups, consistent with the findings of several previous studies [28, 29] . Furthermore, rADC values were significantly increased in the head of the caudate nucleus, although no significant differences were detected in the whole and each part of the putamen in the PSP group. Pathologically, degeneration of the striatum is usually seen in both PSP and MSA. The posterior part of the striatum is severely affected, and the head of the caudate nucleus, namely the anterior part of the striatum, is well preserved in MSA [5] . On the other hand, there is no gradient pathological severity in the striatum in PSP. Therefore, measurement of rADC values in the head of the caudate nucleus, namely the anterior part of the striatum, seems to be important to discriminate PSP from MSA and PD.
As to the globus pallidus, more severe degeneration is histologically seen in the medial part than in the lateral part. In the present study, the rADC values in the entire and medial and lateral parts of the globus pallidus were significantly increased in the PSP group than in the MSA, PD, and control groups, although no significant difference was observed between the medial and lateral parts. The cerebellar dentate nucleus is pathologically affected in PSP, although no significant elevations of rADC values were detected there in the PSP group. Physiologic iron deposition is seen in the globus pallidus and cerebellar dentate nucleus. The susceptibility effect associated with iron deposition might decrease ADC values in such regions [1] .
In the PD group, no elevated rADC values in any regions were observed, consistent with findings in previous studies [17, 19, 29] . Histologically, in PD, loss of neuromelanin cells and gliosis are seen in the substantia nigra and locus ceruleus. Histological changes in the substantia nigra in the midbrain and the locus ceruleus in the pons might be too small to be detected as elevated rADC values in these regions in PD [30] . Furthermore, rADC values in the substantia nigra in PD can be affected by not only physiologic iron deposition but also by increased iron deposition associated with disease progression.
In the present study, rADC values were evaluated in selected anatomical regions associated with MSA, PSP, and PD using a 3-T MRI system. Characteristic lesions in MSA and PSP were detected as elevations of rADC values, as in previous studies that used 1.5-T systems, as previously mentioned [16, 17, 19, 20] . In this study, increased rADC values in the head of the caudate nucleus and posterior putamen, that is the anterior and posterior striatum, were significant among MSA, PSP, and PD. The evaluation of rADC values in separated anatomical regions seems to be a useful method to reflect gradient severity of histopathological changes in MSA and PSP. Furthermore, these additional findings might be due to the ability to achieve fine visualization of brain anatomy associated with the high spatial resolution and high signal-to-noise ratios with 3-T systems [21, 31] .
There were several limitations to the present study. Firstly, there was no evaluation of tissue iron deposition, which could increase susceptibility effects and affect apparent diffusivity. Not only the evaluation of ADC values, but also evaluation of signal changes on T2*WI and/or SWI may be useful, with consideration of susceptibility effects of brain tissue iron [23] , such as in the globus pallidus, putamen, and substantia nigra, as well as in the dentate nucleus. Secondly, there was no evaluation of imaging findings on conventional images. Signal changes and atrophy on conventional images should be correlated with ADC values in each case. Thirdly, there was no comparison of ADC measurement at 1.5 T and that at 3 T.
In order to confirm the value of 3 T in the differential diagnosis among these disorders, we should make a comparison between ADC measurement at 1.5 T and that at 3 T. Fourth, there was a considerable overlap in ADC values among these degenerative diseases although there were statistically significant differences. Not only ADC values but also other parameters, such as atrophy or signal changes on conventional imaging, that is multiparameters, might be useful to differentiate those diseases. Fifth, the correlation between the ADC values and the disease duration was not examined. The correlation between the ADC values and the disease stages or disease duration needs to be examined. Finally, this was a retrospective study with a small number of subjects, and the single observer who evaluated the ADC values was not blinded to the results from the other imaging studies and clinical data. Because of these limitations, the results of this study should be considered preliminary. Further validation is needed with a large number of cases.
Conclusions
Evaluation of rADC values in characteristic lesions in MSA, PSP, and PD by precisely placing ROIs using 3-T systems can be a practical method that provides useful and additional information for differentiation of these degenerative disorders.
